NCTU
Newcastle Neurosurgery Clinical Trials Unit

Neurosurgical Clinical Trial Unit
Neurosurgical Clinical Trial Unit - STASH

.

click on the logo to go to the relevant external trial webpage

STASH

STASH

Multicentre placebo-controlled double-blinded phase II trial assessing the clinical benefits of simvastatin in aneurysmal subarachnoid haemorrhage.

STASH is a multi-centre randomised placebo-controlled trial comparing best medical care to best medical care and an infusion of Magnesium sulphate for 14 days.

Brief inclusion / exclusion criteria

Inclusion:

  • ASAH (confirmed both clinically and radiologically)
  • Aged 18-65 years
  • Reasonable prospect of survival
  • Enrolled within 96 hours of initial bleed

    • Exclusion:

  • Aged less than 18 or more than 65 years
  • Pregnancy
  • Moribund condition on admission
  • In excess of 96 hours from initial bleed
    		•
    .
    Staff Involved

    Principal Investigators:

    Mr. P. Kirkpatrick (Cambridge)

    Prof. A.D. Mendelow

    		 Assigned Registrar:

    Trial Manager:    		 Mr. T. Jones

    Mrs. C. Turner

    IMASH

    Last updated 12 May 2008
    © NCTU